RUSNANO and OCT co-financing clinical trials

OCT in cooperation with the Russian Corporation of Nanotechnologies (RUSNANO) offer nanotech, biotech, medtech, pharma, and
health industry companies the following possibilities to succeed in projects on development of new nanodrugs and nanodiagnostics:

  • Joint financing II-III Phase clinical investigations involving the investments from RUSNANO
  • Financing start-up projects of I-IV Phase clinical studies (obtaining regulatory approval) out of the proceeds of OCT
  • Flexibility in choosing financial investment instruments for the project: equity, loans, leasing, etc.
  • Providing proper project feasibility study to commercialize nanotech project results in Russian market

Please look through the brief presentation Commercialize your R&D projects results in Nanomedicine & Nanodiagnostics and let us know if you are interested in collaboration.

DOWNLOAD PRESENTATION
   СКАЧАТЬ
ПРЕЗЕНТАЦИЮ
Download Nanotech presentation in PDF format Download file as Power Point presentation Download Nanotech presentation in PDF format Download file as Power Point presentation
PDF

(239 kb)		 Power Point
Slideshow
(1650 kb)		 PDF
(226 kb)		 Power Point Slideshow
(1002 kb)